Healios K.K. (OTCMKTS:HLOSF) Short Interest Update

Healios K.K. (OTCMKTS:HLOSF) was the recipient of a significant increase in short interest in the month of October. As of October 31st, there was short interest totalling 62,900 shares, an increase of 24.6% from the October 15th total of 50,500 shares. Based on an average daily volume of 3,700 shares, the days-to-cover ratio is currently 17.0 days.

Healios K.K. Stock Performance

Shares of HLOSF remained flat at 1.50 during trading hours on Friday. The business’s 50 day moving average is 1.62 and its 200-day moving average is 1.32. Healios K.K. has a fifty-two week low of 0.93 and a fifty-two week high of 1.73.

Healios K.K. Company Profile

Healios K.K. engages in the research and development, manufacture, and sale of cell therapy and regenerative medicine products in Japan, Europe, and the United States. The company offers HLCM051 for treatment of ischemic stroke and acute respiratory distress syndrome; HLCN061 for treating solid tumors; HLCR011 for the treatment of retinal pigment epithelium tear and age-related macular degeneration; and HLCL041 for liver disease.